What is Veracyte's restricted cash?

Veracyte (VCYT) reported restricted cash of $1.66M in Q1 2026.

How has Veracyte's restricted cash changed year-over-year?

Veracyte's restricted cash increased by 0.7% year-over-year, from $1.65M to $1.66M.

What is the long-term trend for Veracyte's restricted cash?

Over 5 years (2020 to 2025), Veracyte's restricted cash has grown at a 22.3% compound annual growth rate (CAGR), from $603K to $1.65M.

What does restricted cash mean?

Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.

Veracyte VCYT Restricted Cash

Restricted Cash at other companies

Guardant HealthGH

$112.15M+6.5%

Adaptive BiotechnologiesADPT

$2.71M-0.1%

Bio-Rad LaboratoriesBIO

——

RevvityRVTY

——

Agilent TechnologiesA

——

Charles River LaboratoriesCRL

——

Other financials

Income statement

See full

Revenue$139.1M+21.5%

Gross profit$101.2M+27.2%

Operating income$22.6M+680%

Net income$28.7M+307%

EPS (diluted)$0.35+289%

Balance sheet

See full

Cash & equivalents$264.8M+41.0%

Total debt$39.3M-22.1%

Total equity$1.3B+12.5%

Total assets$1.4B+9.2%

Cash flow

See full

Operating cash flow$35.2M+557%

CapEx$3.0M+62.8%

Free cash flow$32.3M+810%

Valuation

See full

Market cap$4.29B+10.7%

Profitability

See full

Gross margin70.9%+2.9pp

Operating margin14.3%+9.2pp

Net margin16.2%+9.1pp

FCF margin28.7%+11.7pp

Returns & leverage

See full

Return on equity6.9%+4.1pp

Debt / equity0×0.0×

Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashAndCashEquivalents.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Veracyte's restricted cash?: Veracyte (VCYT) reported restricted cash of $1.66M in Q1 2026.
How has Veracyte's restricted cash changed year-over-year?: Veracyte's restricted cash increased by 0.7% year-over-year, from $1.65M to $1.66M.
What is the long-term trend for Veracyte's restricted cash?: Over 5 years (2020 to 2025), Veracyte's restricted cash has grown at a 22.3% compound annual growth rate (CAGR), from $603K to $1.65M.
What does restricted cash mean?: Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.